Skip to main content
Home
Browse by Topic
Issues
Online First
Latest Issue
Issue Archive
Special Issues
PSS Guide
View the Guide
Featured Profiles
Geron
SpringWorks/EMD Serono
Syndax Pharmaceuticals
Special Series
Emerging Data and Trends in HR-Positive/HER2-Negative Breast Cancer
Did You Know? Beyond the Data
Conference Correspondent
DLBCL Download: Emerging Insights From ASCO 2026
OFS Summit
Multimedia
All Videos
Cancer, Clearly
Case-Based Exchanges
Best Practices in Breast Cancer Therapy | OFS
Interview with the Innovators
Rapid Reactions
Webinars
Quick Quiz
Subscribe
Home
Browse by Topic
Issues
Online First
Latest Issue
Issue Archive
Special Issues
PSS Guide
View the Guide
Featured Profiles
Geron
SpringWorks/EMD Serono
Syndax Pharmaceuticals
Special Series
Emerging Data and Trends in HR-Positive/HER2-Negative Breast Cancer
Did You Know? Beyond the Data
Conference Correspondent
DLBCL Download: Emerging Insights From ASCO 2026
OFS Summit
Multimedia
All Videos
Cancer, Clearly
Case-Based Exchanges
Best Practices in Breast Cancer Therapy | OFS
Interview with the Innovators
Rapid Reactions
Webinars
Quick Quiz
Subscribe
Geoff Oxnard, MD
Authored Items
Best Practices: Evolving Understanding of Molecular Diagnostics and Biomarkers in Lung Cancer
By
Geoff Oxnard, MD
;
Lauren Ritterhouse, MD, PhD
September 2018, Vol 8, No 9
ASCO 2018 Highlights
,
Biomarkers
,
Interview with the Innovators
At ASCO 2018,
Oncology Practice Management
(
OPM
) discussed the current state of genetics and genomic testing, the increasing understanding of biomarkers, and how they influence the treatment of patients with lung cancer.
Read More ›